|
1
|
January CT, Wann LS, Alpert JS, Calkins H,
Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD,
Field ME, et al: 2014 AHA/ACC/HRS guideline for the management of
patients with atrial fibrillation: A report of the American College
of Cardiology/American Heart Association Task Force on practice
guidelines and the Heart Rhythm Society. Circulation.
130:e199–e267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miyasaka Y, Barnes ME, Gersh BJ, Cha SS,
Bailey KR, Abhayaratna WP, Seward JB and Tsang TS: Secular trends
in incidence of atrial fibrillation in olmsted county, minnesota,
1980 to 2000 and implications on the projections for future
prevalence. Circulation. 114:119–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duncan ME, Pitcher A and Goldacre MJ:
Atrial fibrillation as a cause of death increased steeply in
England between 1995 and 2010. Europace. 16:797–802. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coyne KS, Paramore C, Grandy S, Mercader
M, Reynolds M and Zimetbaum P: Assessing the direct costs of
treating nonvalvular atrial fibrillation in the United States.
Value Health. 9:348–356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ball J, Carrington MJ, McMurray JJ and
Stewart S: Atrial fibrilation: Profile and burden of an evolving
epidemic in the 21st century. Int J Cardiol. 167:1807–1824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mazurek T, Kiliszek M, Kobylecka M,
Skubisz-Głuchowska J, Kochman J, Filipiak K, Królicki L and Opolski
G: Relation of proinflammatory activity of epicardial adipose
tissue to the occurrence of atrial fibrillation. Am J Cardiol.
113:1505–1508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu G, Yan YP, Zheng XX, Xu YL, Lu J, Hui
RT and Huang XH: Meta-analysis of nonsteroidal anti-inflammatory
drug use and risk of atrial fibrillation. Am J Cardiol.
114:1523–1529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hong K and Xiong Q: Genetic basis of
atrial fibrillation. Curr Opin Cardiol. 29:220–226. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.
|
|
10
|
Shi HF, Yang JF, Wang Q, Li RG, Xu YJ, Qu
XK, Fang WY, Liu X and Yang YQ: Prevalence and spectrum of GJA5
mutations associated with lone atrial fibrillation. Mol Med Rep.
7:767–774. 2013.PubMed/NCBI
|
|
11
|
Sun Y, Yang YQ, Gong XQ, Wang XH, Li RG,
Tan HW, Liu X, Fang WY and Bai D: Novel germline GJA5/connexin40
mutations associated with lone atrial fibrillation impair gap
junctional intercellular communication. Hum Mutat. 34:603–609.
2013.PubMed/NCBI
|
|
12
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: A novel NKX2.5 loss-of-function mutation responsible for
familial atrial fibrillation. Int J Mol Med. 31:1119–1126.
2013.PubMed/NCBI
|
|
13
|
Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang
WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations
associated with idiopathic atrial fibrillation. Clinics (Sao
Paulo). 68:777–784. 2013. View Article : Google Scholar
|
|
14
|
Yu H, Xu JH, Song HM, Zhao L, Xu WJ, Wang
J, Li RG, Xu L, Jiang WF, Qiu XB, et al: Mutational spectrum of the
NKX2-5 gene in patients with lone atrial fibrillation. Int J Med
Sci. 11:554–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li RG, Wang Q, Xu YJ, Zhang M, Qu XK, Liu
X, Fang WY and Yang YQ: Mutations of the SCN4B-encoded sodium
channel β4 subunit in familial atrial fibrillation. Int J Mol Med.
32:144–150. 2013.PubMed/NCBI
|
|
16
|
Beavers DL, Wang W, Ather S, Voigt N,
Garbino A, Dixit SS, Landstrom AP, Li N, Wang Q, Olivotto I, et al:
Mutation E169K in junctophilin-2 causes atrial fibrillation due to
impaired RyR2 stabilization. J Am Coll Cardiol. 62:2010–2019. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olesen MS, Refsgaard L, Holst AG, Larsen
AP, Grubb S, Haunsø S, Svendsen JH, Olesen SP, Schmitt N and Calloe
K: A novel KCND3 gain-of-function mutation associated with
early-onset of persistent lone atrial fibrillation. Cardiovasc Res.
98:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang YQ, Xu YJ, Li RG, Qu XK, Fang WY and
Liu X: Prevalence and spectrum of PITX2c mutations associated with
familial atrial fibrillation. Int J Cardiol. 168:2873–2876. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou YM, Zheng PX, Yang YQ, Ge ZM and Kang
WQ: A novel PITX2c loss-of-function mutation underlies lone atrial
fibrillation. Int J Mol Med. 32:827–834. 2013.PubMed/NCBI
|
|
20
|
Wang J, Zhang DF, Sun YM and Yang YQ: A
novel PITX2c loss-of-function mutation associated with familial
atrial fibrillation. Eur J Med Genet. 57:25–31. 2014. View Article : Google Scholar
|
|
21
|
Qiu XB, Xu YJ, Li RG, Xu L, Liu X, Fang
WY, Yang YQ and Qu XK: PITX2C loss-of-function mutations
responsible for idiopathic atrial fibrillation. Clinics (Sao
Paulo). 69:15–22. 2014. View Article : Google Scholar
|
|
22
|
Wang J, Zhang DF, Sun YM, Li RG, Qiu XB,
Qu XK, Liu X, Fang WY and Yang YQ: NKX2-6 mutation predisposes to
familial atrial fibrillation. Int J Mol Med. 34:1581–1590.
2014.PubMed/NCBI
|
|
23
|
Macri V, Mahida SN, Zhang ML, Sinner MF,
Dolmatova EV, Tucker NR, McLellan M, Shea MA, Milan DJ, Lunetta KL,
et al: A novel trafficking-defective HCN4 mutation is associated
with early-onset atrial fibrillation. Heart Rhythm. 11:1055–1062.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sinner MF, Tucker NR, Lunetta KL, Ozaki K,
Smith JG, Trompet S, Bis JC, Lin H, Chung MK, Nielsen JB, et al:
Integrating genetic, transcriptional, and functional analyses to
identify 5 novel genes for atrial fibrillation. Circulation.
130:1225–1235. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Holm H, Gudbjartsson DF, Arnar DO,
Thorleifsson G, Thorgeirsson G, Stefansdottir H, Gudjonsson SA,
Jonasdottir A, Mathiesen EB, Njølstad I, et al: Several common
variants modulate heart rate, PR interval and QRS duration. Nat
Genet. 42:117–122. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zang X, Zhang S, Xia Y, Li S, Fu F, Li X,
Wang F, Zhang R, Tian X, Gao L, et al: SNP rs3825214 in TBX5 is
associated with lone atrial fibrillation in Chinese Han population.
PLoS One. 8:e649662013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greulich F, Rudat C and Kispert A:
Mechanisms of T-box gene function in the developing heart.
Cardiovasc Res. 91:212–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Postma AV, van de Meerakker JB, Mathijssen
IB, Barnett P, Christoffels VM, Ilgun A, Lam J, Wilde AA, Lekanne
Deprez RH and Moorman AF: A gain-of-function TBX5 mutation is
associated with atypical Holt-Oram syndrome and paroxysmal atrial
fibrillation. Circ Res. 102:1433–1442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
World Medical Association: World Medical
Association Declaration of Helsinki: Ethical principles for medical
research involving human subjects. J Postgrad Med. 48:206–208.
2002.PubMed/NCBI
|
|
30
|
Zhang XL, Qiu XB, Yuan F, Wang J, Zhao CM,
Li RG, Xu L, Xu YJ, Shi HY, Hou XM, et al: TBX5 loss-of-function
mutation contributes to familial dilated cardiomyopathy. Biochem
Biophys Res Commun. 459:166–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bruneau BG, Logan M, Davis N, Levi T,
Tabin CJ, Seidman JG and Seidman CE: Chamber-specific cardiac
expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev
Biol. 211:100–108. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moskowitz IP, Pizard A, Patel VV, Bruneau
BG, Kim JB, Kupershmidt S, Roden D, Berul CI, Seidman CE and
Seidman JG: The T-Box transcription factor Tbx5 is required for the
patterning and maturation of the murine cardiac conduction system.
Development. 131:4107–4116. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bruneau BG, Nemer G, Schmitt JP, Charron
F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE
and Seidman JG: A murine model of Holt-Oram syndrome defines roles
of the T-box transcription factor Tbx5 in cardiogenesis and
disease. Cell. 106:709–721. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng S, Keyes MJ, Larson MG, McCabe EL,
Newton-Cheh C, Levy D, Benjamin EJ, Vasan RS and Wang TJ: Long-term
outcomes in individuals with prolonged PR interval or first-degree
atrioventricular block. JAMA. 301:2571–2577. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soliman EZ, Prineas RJ, Case LD, Zhang ZM
and Goff DC Jr: Ethnic distribution of ECG predictors of atrial
fibrillation and its impact on understanding the ethnic
distribution of ischemic stroke in the Atherosclerosis Risk in
Communities (ARIC) study. Stroke. 40:1204–1211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schnabel RB, Sullivan LM, Levy D, Pencina
MJ, Massaro JM, D'Agostino RB Sr, Newton-Cheh C, Yamamoto JF,
Magnani JW, Tadros TM, et al: Development of a risk score for
atrial fibrillation (Framingham Heart Study): A community-based
cohort study. Lancet. 373:739–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Macfarlane PW, Murray H, Sattar N, Stott
DJ, Ford I, Buckley B, Jukema JW, Westendorp RG and Shepherd J: The
incidence and risk factors for new onset atrial fibrillation in the
PROSPER study. Europace. 13:634–639. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hiroi Y, Kudoh S, Monzen K, Ikeda Y,
Yazaki Y, Nagai R and Komuro I: Tbx5 associates with Nkx2-5 and
synergistically promotes cardiomyocyte differentiation. Nat Genet.
28:276–280. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, et al: GATA4 mutations cause human
congenital heart defects and reveal an interaction with TBX5.
Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Linhares VL, Almeida NA, Menezes DC,
Elliott DA, Lai D, Beyer EC, Campos de Carvalho AC and Costa MW:
Transcriptional regulation of the murine Connexin40 promoter by
cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc Res. 64:402–411.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Maitra M, Schluterman MK, Nichols HA,
Richardson JA, Lo CW, Srivastava D and Garg V: Interaction of Gata4
and Gata6 with Tbx5 is critical for normal cardiac development. Dev
Biol. 326:368–377. 2009. View Article : Google Scholar :
|
|
42
|
Jiang JQ, Shen FF, Fang WY, Liu X and Yang
YQ: Novel GATA4 mutations in lone atrial fibrillation. Int J Mol
Med. 28:1025–1032. 2011.PubMed/NCBI
|
|
43
|
Li J, Liu WD, Yang ZL and Yang YQ: Novel
GATA6 loss-of-function mutation responsible for familial atrial
fibrillation. Int J Mol Med. 30:783–790. 2012.PubMed/NCBI
|
|
44
|
Hodgson-Zingman DM, Karst ML, Zingman LV,
Heublein DM, Darbar D, Herron KJ, Ballew JD, de Andrade M, Burnett
JC Jr and Olson TM: Atrial natriuretic peptide frameshift mutation
in familial atrial fibrillation. N Engl J Med. 359:158–165. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
McDermott DA, Hatcher CJ and Basson CT:
Atrial fibrillation and other clinical manifestations of altered
TBX5 dosage in typical Holt-Oram syndrome. Circ Res. 103:e962008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Patel C, Silcock L, McMullan D, Brueton L
and Cox H: TBX5 intragenic duplication: A family with an atypical
Holt-Oram syndrome phenotype. Eur J Hum Genet. 20:863–869. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kimura M, Kikuchi A, Ichinoi N and Kure S:
Novel TBX5 duplication in a Japanese family with Holt-Oram
syndrome. Pediatr Cardiol. 36:244–247. 2015. View Article : Google Scholar
|
|
48
|
Al-Qattan MM and Abou Al-Shaar H:
Molecular basis of the clinical features of Holt-Oram syndrome
resulting from missense and extended protein mutations of the TBX5
gene as well as TBX5 intragenic duplications. Gene. 560:129–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hatcher CJ, Kim MS, Mah CS, Goldstein MM,
Wong B, Mikawa T and Basson CT: TBX5 transcription factor regulates
cell proliferation during cardiogenesis. Dev Biol. 230:177–188.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hatcher CJ, Diman NY, Kim MS, Pennisi D,
Song Y, Goldstein MM, Mikawa T and Basson CT: A role for Tbx5 in
proepicardial cell migration during cardiogenesis. Physiol
Genomics. 18:129–140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liberatore CM, Searcy-Schrick RD and
Yutzey KE: Ventricular expression of tbx5 inhibits normal heart
chamber development. Dev Biol. 223:169–180. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Al-Qattan MM and Abou Al-Shaar H:
Molecular basis of the clinical features of Holt-Oram syndrome
resulting from missense and extended protein mutations of the TBX5
gene as well as TBX5 intragenic duplications. Gene. 560:129–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mori AD, Zhu Y, Vahora I, Nieman B,
Koshiba-Takeuchi K, Davidson L, Pizard A, Seidman JG, Seidman CE,
Chen XJ, et al: Tbx5-dependent rheostatic control of cardiac gene
expression and morphogenesis. Dev Biol. 297:566–586. 2006.
View Article : Google Scholar : PubMed/NCBI
|
